Project Grant HT94252510317
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$300K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10021, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $296,093 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Hospital For Special Surgery Fund, Inc. (doing business as HSS Foundation), a non-profit organization. The grant supports research to investigate how endothelial cell S1PR1 shapes the autoimmune response and may attenuate injury in experimental lupus nephritis. The award period is from September 1, 2025 to August 31, 2027. HSS...
The Department of the Army Medical Command awarded a $1,499,782 Project Grant to the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery under the Military Medical Research and Development program. This three-year award beginning July 1, 2022 will support research into photosensitivity and lymph node immune responses in lupus. The Military Medical Research and Development program aims to advance biomedical research that improves health care for...
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $300,000 Project Grant to Duke University to investigate the "Complement-Activating Properties of Anti-Sm/RNP Antibodies in SLE". This 2-year research effort, starting on September 1, 2024 and ending on August 31, 2026, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The Military Medical Research and...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
The University of Houston System was awarded a $999,465 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on September 1, 2025, supports the development of selective spleen-targeted nanoparticles as drug delivery vehicles for the treatment of lupus. This research aims to transform healthcare for military service members and the broader public by advancing innovative biomedical solutions. The program...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
The Department of the Army Medical Command awarded a $750,000 Project Grant to The Trustees of Columbia University in the City of New York under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant aims to validate Systemic Lupus Erythematosus (SLE) virtual outcome measures through three specific objectives over a three-year period ending August 2024. Sub-awards were provided to six institutions, including the Oklahoma Medical Research Foundation and the...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...
This $997,821 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research into the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee is Trustees of Dartmouth College, with sub-awards to The Johns Hopkins University and Dartmouth-Hitchcock Clinic. This multi-institutional effort will investigate the underlying mechanisms of neutrophil-driven pathology in lupus nephritis, with...
The federal Project Grant award of $3,300,817.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at the Icahn School of Medicine at Mount Sinai (ISMMS) to leverage personalized stem cell therapy and overcome airway reconstruction challenges. This research aims to transform healthcare for military service members, veterans, and the broader public by addressing critical health...